The Deyx Briefing: Is That $300 Focus Device Worth It?

Adult ADHD isn’t a niche diagnosis anymore.

The CDC estimates 15.5 million U.S. adults have  an attention deficit/hyperactivity disorder (ADHD) diagnosis. ADHD is a brain-based condition that makes it harder to regulate attention, impulses, and follow-through — and it’s not because you don’t care. Rather, the brain systems that manage focus and execution run less efficiently.

Roughly half of the 15.5 million are diagnosed in adulthood — not childhood. And numbers have accelerated since 2020, driven by telehealth expansion, reduced stigma, and diagnostic criteria that finally capture how ADHD shows up in women and late-identified adults. 

Attention span is not just inconvenient. It can influence unmanaged impulsivity, cardiovascular risk, substance exposure, injury, and inconsistent health behaviors that compound over decades.

In other words, ADHD can influence lifespan. Data from 10 million people suggests that adults with ADHD have a reduced life expectancy — approximately 6.8 years for men and 8.6 years for women, according to a 2025 matched cohort study in The British Journal of Psychiatry.

This is not about productivity. It’s about stability over 30 years. The quality of management tools starts to matter a lot more now.

It’s important to note that medication remains the gold standard for improving longevity for those with ADHD, backed by decades of strong clinical data. But side effects, shortages, stigma, and personal preference drive many people to seek apps or “natural” alternatives. The demand makes sense. The evidence behind most of those alternatives is the weak link.

So when the market floods with apps, headsets, focus devices, and “brain training” subscriptions, this isn’t harmless experimentation.

Get your ticket to the Livelong Women’s Health Summit today because prices increase tomorrow, March 6th!

When sustained attention feels like a character flaw, the market shows up fast….ADHD apps, headsets, Neurofeedback clinics (clinics that use sensors and real-time brainwave feedback to try to “train” attention patterns over repeated sessions, often marketed as a drug-free way to improve focus), and “neuroscience-backed” subscriptions.

The $300 focus device your algorithm keeps insisting on will ‘change your life.’

A few tools have cleared meaningful bars. Most are selling structure, not treatment.

Here’s how the stack actually breaks down.

In 2020, a video game became the first FDA-cleared digital therapeutic for ADHD.

Not a timer.
Not “deep focus audio.”
An actual prescription intervention for kids 8–17.

It cleared based on multiple clinical trials (600+ participants), including a randomized controlled study published in The Lancet Digital Health showing measurable improvements in attention function. It’s since been expanded over-the-counter for adults.

Is it a miracle? No. Effects are modest. Not everyone responds. It’s meant to sit alongside medication or therapy, not replace them.

But here’s the difference: someone had to run trials, publish data, and survive regulatory review before selling it.

That bar alone separates it from most of the category.

 Are you feeling overwhelmed with all the mental health information out there? Do you wish you had access to world-renowned experts who specialize in this area? Join Dr. Sasha Hamdani at the Livelong Women’s Health Summit in San Francisco April 17-18 to get honest, practical answers on brain aging and what you can do.

These products may work, but the story is less convincing.

A forehead-worn device that stimulates an important nerve in the brain during sleep. It was FDA-cleared in 2019 for children not on ADHD medication. The original study looked promising: about half the kids in the active group showed meaningful improvement versus far fewer in the sham group.

Then a larger, more rigorous replication trial landed in 2026.

Result: no meaningful difference from sham.

When the control condition improved, the signal disappeared.

Early data can glow. Replication is where things get uncomfortable.

Neurofeedback has been around for decades. You watch a screen, your brain waves are measured, and you try to train them into a better pattern.

Individual trials often show benefits. But when researchers pool dozens of trials together and look only at blinded assessments — the gold standard — the effects tend to shrink or vanish.

It’s not necessarily fake.

It’s just unresolved.

At $100–$200 per session, often 20–40 sessions deep, you’re buying uncertainty at a premium.

A large review of over 100 ADHD apps found that none provided solid scientific evidence of effectiveness or safety.

That includes:

Can they help? Yes.

Structure helps. External scaffolding helps.

But anecdotes aren't the same as controlled evidence. These are productivity tools marketed toward ADHD — not medical treatments.

That distinction matters because of the psychological cost. Cycling through tools that don’t move the needle doesn’t just waste money. It erodes belief. “Nothing works for me” becomes the default narrative.

That story is often more damaging than the distraction itself.

Looking for an encouraging community of women like you? Join the Livelong Women’s Circle today and find support for your physical, mental, and emotional health as you embrace your golden years.

👉 Join the Livelong Women’s Circle

💰 Money — High. Apps: $10–$50/month; devices: $300–$1,000; neurofeedback: thousands. 

⏰ Time — High. Many apps, devices, and clinical sessions take time to both master and interpret. The more inputs you have, the less time you get back with increased focus.

🧠 Cognitive Load — High. ADHD already makes executive function expensive. Many tools add: dashboards, streak systems, and progress metrics. More inputs. More decisions. More subtle pressure to optimize.

Before anything gets time or money:

Simple question: does this make my life lighter or heavier?

The ADHD tech market isn’t empty. It’s just crowded with products that borrow the tone of medicine without carrying the burden of proof.

Attention is already expensive. Be careful what you add to it.

We’re inviting vendors, brands, and practitioners who support women’s health, longevity, and well-being to partner with Livelong.

If your work prioritizes evidence, ethics, and real impact over trends, you’re our kind of collaborator.

👉 Explore partnership opportunities

Livelong is looking for community ambassadors — women who care deeply about thoughtful health conversations, advocacy, and connection.

If you believe women deserve better data, better care, and better dialogue, we’d love to work with you.

👉 Become a Livelong Ambassador

(Reviewed, not endorsed)

Curious about your health? My counterpart, Liv, can search across everything we’ve published and help you dig into the questions to find the answers.

The information provided about wellness and health is for general informational and educational purposes only. We are not licensed medical professionals, and the content here should not be considered medical advice. Talk to a doctor before trying any of these suggestions.